Nu Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 145,713 | 128,634 | 107,515 | -146,594 | -110,489 |
| Depreciation Amortization | 39,349 | 27,258 | 14,206 | 69,810 | 53,361 |
| Income taxes - deferred | -8,154 | -6,793 | 631 | -55,477 | -7,625 |
| Accounts receivable | 1,318 | -8,660 | -5,878 | -7,763 | 5,074 |
| Accounts payable and accrued liabilities | -6,865 | -6,824 | -1,439 | -7,294 | -10,556 |
| Other Working Capital | -41,183 | -26,294 | -18,812 | -28,335 | -38,667 |
| Other Operating Activity | -66,513 | -71,137 | -95,834 | 287,395 | 194,859 |
| Operating Cash Flow | $63,665 | $36,184 | $389 | $111,742 | $85,957 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23,517 | -13,602 | -13,584 | -41,583 | -29,000 |
| Net Acquisitions | 193,725 | 193,725 | 193,725 | N/A | N/A |
| Purchase Of Investment | 0 | 0 | N/A | -14,757 | -13,718 |
| Sale Of Investment | 10,214 | 10,214 | 1,403 | 18,378 | 18,378 |
| Investing Cash Flow | $180,422 | $190,337 | $181,544 | $-37,962 | $-24,340 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 55,000 | 15,000 | N/A | 15,000 | 15,000 |
| Debt Repayment | -221,755 | -161,120 | -155,621 | -127,886 | -87,302 |
| Common Stock Issued | -1,171 | -1,142 | -1,162 | -2,063 | -2,004 |
| Common Stock Repurchased | -10,020 | -5,012 | -5,012 | N/A | N/A |
| Dividend Paid | -8,928 | -5,966 | -3,002 | -11,927 | -8,944 |
| Other Financing Activity | 2,971 | 1,213 | -1,498 | -6,300 | -6,300 |
| Financing Cash Flow | $-183,903 | $-157,027 | $-166,295 | $-133,176 | $-89,550 |
| Exchange Rate Effect | 4,720 | 7,782 | 1,249 | -9,778 | -373 |
| Beginning Cash Position | 186,883 | 186,883 | 186,883 | 256,057 | 256,057 |
| End Cash Position | 251,787 | 264,159 | 203,770 | 186,883 | 227,751 |
| Net Cash Flow | $64,904 | $77,276 | $16,887 | $-69,174 | $-28,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | 63,665 | 36,184 | 389 | 111,742 | 85,957 |
| Capital Expenditure | -23,517 | -13,602 | -13,584 | -41,583 | -29,000 |
| Free Cash Flow | 40,148 | 22,582 | -13,195 | 70,159 | 56,957 |